You can go.
Capital Pharmaceutical Holdings has been authorized more than 100 invention patents worldwide, obtained 16 national first-class clinical approvals for new drugs (including cooperative research and development projects), and won the national "Twelfth Five-Year Plan" and "Thirteenth Five-Year Plan". There are 8 major new drug creation projects in the Five-Year Plan.
Currently, 2 new drugs have entered clinical phase III, 2 new drugs have entered clinical phase II, and 10 new drugs have entered clinical phase I.
Capital Capital Holdings’ financing inflow exceeded 30 million yuan, and its financing balance increased by 294.16% from the previous day, ranking first in the Shanghai and Shenzhen Stock Exchanges. Judging from recent capital trends and financing data, Shougang Pharmaceutical Holdings is likely to be scrambled by capital.